Effects of imeglimin on experimental diabetic neuropathy in streptozotocin‐induced diabetic rats

Key Points

• The aim is to investigate the therapeutic effects of imeglimin on diabetic neuropathy in a rat model.
• Induced diabetes in rats using streptozotocin.
• Administered imeglimin to assess its effects on diabetic neuropathy.
• Conducted behavioral and physiological assessments of neuropathy.
• Imeglimin treatment significantly improved symptoms of diabetic neuropathy in rats.
• Behavioral tests showed enhanced sensory function after imeglimin administration.

Abstract